Treatment of HIV-associated nephropathies

Usama Elewa, Ana Maria Sandri, Stacey Rizza, Fernando Custodio Fervenza

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

In patients with HIV, the use of highly active antiretroviral therapy has improved life expectancy. At the same time, this increase in life expectancy has been associated with a higher frequency of chronic kidney disease due to factors other than HIV infection. Besides HIV-associated nephropathy, a number of different types of immune complex and non-immune complex-mediated processes have been identified on kidney biopsies, including vascular disease (nephrosclerosis), diabetes, and drug-related renal injury. In this setting, renal biopsy needs to be considered in order to obtain the correct diagnosis in individual patients with HIV and kidney impairment. Many issues regarding the optimal treatment of the different pathological processes affecting the kidneys of these patients have remained unresolved. Further research is needed in order to optimize treatment and renal outcomes in patients with HIV and kidney disease.

Original languageEnglish (US)
JournalNephron - Clinical Practice
Volume118
Issue number4
DOIs
StatePublished - Jul 2011

Fingerprint

AIDS-Associated Nephropathy
Kidney
HIV
Life Expectancy
Therapeutics
Nephrosclerosis
Biopsy
Highly Active Antiretroviral Therapy
Kidney Diseases
Pathologic Processes
Antigen-Antibody Complex
Chronic Renal Insufficiency
Vascular Diseases
HIV Infections
Wounds and Injuries
Research
Pharmaceutical Preparations

Keywords

  • Human immunodeficiency virus
  • Nephropathy
  • Therapy

ASJC Scopus subject areas

  • Nephrology

Cite this

Treatment of HIV-associated nephropathies. / Elewa, Usama; Sandri, Ana Maria; Rizza, Stacey; Fervenza, Fernando Custodio.

In: Nephron - Clinical Practice, Vol. 118, No. 4, 07.2011.

Research output: Contribution to journalArticle

@article{18bf51b01b8e43649737af5b29aa5a15,
title = "Treatment of HIV-associated nephropathies",
abstract = "In patients with HIV, the use of highly active antiretroviral therapy has improved life expectancy. At the same time, this increase in life expectancy has been associated with a higher frequency of chronic kidney disease due to factors other than HIV infection. Besides HIV-associated nephropathy, a number of different types of immune complex and non-immune complex-mediated processes have been identified on kidney biopsies, including vascular disease (nephrosclerosis), diabetes, and drug-related renal injury. In this setting, renal biopsy needs to be considered in order to obtain the correct diagnosis in individual patients with HIV and kidney impairment. Many issues regarding the optimal treatment of the different pathological processes affecting the kidneys of these patients have remained unresolved. Further research is needed in order to optimize treatment and renal outcomes in patients with HIV and kidney disease.",
keywords = "Human immunodeficiency virus, Nephropathy, Therapy",
author = "Usama Elewa and Sandri, {Ana Maria} and Stacey Rizza and Fervenza, {Fernando Custodio}",
year = "2011",
month = "7",
doi = "10.1159/000323666",
language = "English (US)",
volume = "118",
journal = "Experimental Nephrology",
issn = "1660-8151",
publisher = "S. Karger AG",
number = "4",

}

TY - JOUR

T1 - Treatment of HIV-associated nephropathies

AU - Elewa, Usama

AU - Sandri, Ana Maria

AU - Rizza, Stacey

AU - Fervenza, Fernando Custodio

PY - 2011/7

Y1 - 2011/7

N2 - In patients with HIV, the use of highly active antiretroviral therapy has improved life expectancy. At the same time, this increase in life expectancy has been associated with a higher frequency of chronic kidney disease due to factors other than HIV infection. Besides HIV-associated nephropathy, a number of different types of immune complex and non-immune complex-mediated processes have been identified on kidney biopsies, including vascular disease (nephrosclerosis), diabetes, and drug-related renal injury. In this setting, renal biopsy needs to be considered in order to obtain the correct diagnosis in individual patients with HIV and kidney impairment. Many issues regarding the optimal treatment of the different pathological processes affecting the kidneys of these patients have remained unresolved. Further research is needed in order to optimize treatment and renal outcomes in patients with HIV and kidney disease.

AB - In patients with HIV, the use of highly active antiretroviral therapy has improved life expectancy. At the same time, this increase in life expectancy has been associated with a higher frequency of chronic kidney disease due to factors other than HIV infection. Besides HIV-associated nephropathy, a number of different types of immune complex and non-immune complex-mediated processes have been identified on kidney biopsies, including vascular disease (nephrosclerosis), diabetes, and drug-related renal injury. In this setting, renal biopsy needs to be considered in order to obtain the correct diagnosis in individual patients with HIV and kidney impairment. Many issues regarding the optimal treatment of the different pathological processes affecting the kidneys of these patients have remained unresolved. Further research is needed in order to optimize treatment and renal outcomes in patients with HIV and kidney disease.

KW - Human immunodeficiency virus

KW - Nephropathy

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=79551555011&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79551555011&partnerID=8YFLogxK

U2 - 10.1159/000323666

DO - 10.1159/000323666

M3 - Article

C2 - 21293158

AN - SCOPUS:79551555011

VL - 118

JO - Experimental Nephrology

JF - Experimental Nephrology

SN - 1660-8151

IS - 4

ER -